In modern cancer treatment, physicians typically develop comprehensive treatment plans based on each patient’s condition. Among the available options, radiotherapy and chemotherapy remain two of the most common and essential treatment approaches.
● Radiotherapy works by using high-energy radiation to damage the DNA of cancer cells, thereby inhibiting their growth and division.
● Chemotherapy uses drugs to interfere with the proliferation of cancer cells in order to kill or control tumor growth.
These two treatment modalities play important roles in the management of many malignancies, including head and neck cancer, lung cancer, breast cancer, and ovarian cancer.
👉 While reviewing information related to cancer therapies, DengYue Medicine observed that with the advancement of medical science, the focus of cancer treatment has gradually expanded beyond simply “eliminating tumor cells.” Increasingly, attention is also being paid to how to reduce damage to normal tissues while maintaining treatment efficacy.
As a result, supportive medications designed to reduce the side effects of radiotherapy and chemotherapy have gradually become an important part of comprehensive cancer care.
1. Common Side Effects of Radiotherapy and Chemotherapy
It is well known that while radiotherapy and chemotherapy destroy cancer cells, they may also affect healthy tissues. This occurs because many treatment approaches cannot completely distinguish between malignant and normal cells, which may lead to various adverse effects during therapy.
For example, when platinum-based chemotherapy drugs are used, patients may experience organ toxicity. One well-known example is kidney toxicity caused by Cisplatin. In addition, during radiotherapy for head and neck cancers, radiation may damage the salivary glands, leading to xerostomia (dry mouth). This condition can affect eating, swallowing, and speaking, and may also impact oral health, significantly influencing patients’ long-term quality of life.
Beyond organ damage, radiotherapy and chemotherapy may also cause systemic side effects such as nausea, vomiting, and fatigue. In some cases, if the toxicity becomes severe, physicians may need to adjust the treatment plan, such as reducing the drug dosage or extending the treatment interval. Although these adjustments can help alleviate side effects, they may also affect the continuity and effectiveness of the treatment regimen.
Therefore, in the field of oncology, how to maintain treatment efficacy while minimizing toxicity has become an important focus of medical research.
2. The Emergence of Cytoprotective Agents
Amifostine: A Supportive Drug Designed to Protect Healthy Cells
Against this background, reducing treatment-related toxicity while preserving therapeutic effectiveness has become a key goal in both clinical practice and research.
💉 In this context, Amifostine (Amifostine for Injection) is considered a representative cytoprotective drug. Amifostine is a prodrug that, once inside the body, is converted into an active metabolite by alkaline phosphatase in normal tissues. This metabolite helps scavenge free radicals and reduce DNA damage, thereby protecting healthy cells from the harmful effects of radiotherapy or chemotherapy.
👉 In clinical practice, amifostine is typically administered before radiotherapy or chemotherapy to reduce treatment-related toxicities. For example, in chemotherapy regimens containing cisplatin, amifostine can lower the risk of kidney toxicity. In radiotherapy for head and neck cancers, the drug may also help reduce salivary gland damage and decrease the incidence of xerostomia. Through these mechanisms, amifostine can improve patients’ tolerance to treatment and help ensure that therapy proceeds more smoothly.
👉 From a broader perspective, modern oncology has gradually shifted from simply “destroying cancer cells” toward a more comprehensive and refined treatment approach. In addition to anticancer drugs, various supportive therapies continue to evolve, including antiemetic medications, hematopoietic growth factors, and cytoprotective agents. As a representative of this category, amifostine plays a meaningful role in enhancing treatment safety and improving patients’ quality of life.
Overall, although amifostine for injection is not a drug that directly targets tumor cells, it plays an important supportive role in comprehensive cancer therapy by protecting normal tissues, reducing the toxic effects of radiotherapy and chemotherapy, and improving patients’ tolerance to treatment.
🤔 Cancer treatment is a complex and systemic battle. Radiotherapy and chemotherapy act as the primary weapons against tumors, while supportive drugs such as amifostine serve as the protective shield that helps safeguard the body. Understanding these often overlooked supportive therapies allows us to better appreciate the full picture of modern oncology care and helps patients face the journey of cancer treatment with fewer burdens and greater confidence.
DengYueMed will continue to follow global developments in cancer therapies and innovative drugs, sharing relevant insights and information with the community.
No comments:
Post a Comment